SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 270.53 |
| Enterprise Value ($M) | 202.40 |
| Book Value ($M) | 92.43 |
| Book Value / Share | 2.06 |
| Price / Book | 2.93 |
| NCAV ($M) | 70.57 |
| NCAV / Share | 1.58 |
| Price / NCAV | 3.83 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.26 |
| Return on Assets (ROA) | -0.19 |
| Return on Equity (ROE) | -0.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.54 |
| Current Ratio | 3.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 99.06 |
| Assets | 120.92 |
| Liabilities | 28.49 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Paradigm Biocapital Advisors LP | 9.20 | 85.89 | |
| 13G/A | Vanguard Group Inc | 4.56 | 0.00 | |
| 13G/A | WG Biotech ApS | 10.70 | 9.18 | |
| 13G/A | HBM Healthcare Investments (Cayman) Ltd. | 7.60 | -13.53 | |
| 13G/A | Acorn Bioventures, L.p. | 6.30 | 18.71 | |
| 13G/A | BlackRock, Inc. | 6.70 | 13.12 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 44,917 | 280,530 | 16.01 | |
| 36,359 | 188,675 | 19.27 | |
| 62,316 | 504,755 | 12.35 | |
| 145,778 | 657,966 | 22.16 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| XBIT – XBiotech Inc. | XERS – Xeris Biopharma Holdings, Inc. |
| XLO – Xilio Therapeutics, Inc. | ZVRA – Zevra Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io